{"id":"https://openalex.org/W4362610285","doi":"https://doi.org/10.1158/1535-7163.22509942","title":"Supplementary Figures S1-S7; Supplementary Tables S1-S7; and Supplementary Materials and Methods from Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical Properties","display_name":"Supplementary Figures S1-S7; Supplementary Tables S1-S7; and Supplementary Materials and Methods from Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical Properties","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362610285","doi":"https://doi.org/10.1158/1535-7163.22509942"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22509942","doi":"https://doi.org/10.1158/1535-7163.22509942","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22509942","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"parent_works":[],"lineage":["https://openalex.org/W4362610285"],"child_works_count":0,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1535-7163.22509942","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050034826","display_name":"Liangxian Cao","orcid":"https://orcid.org/0000-0002-7979-1612","observed_orcids":["https://orcid.org/0000-0002-7979-1612"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Liangxian Cao","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":"https://orcid.org/0000-0002-7979-1612","affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063440637","display_name":"Marla L. Weetall","orcid":"https://orcid.org/0000-0002-2013-8096","observed_orcids":["https://orcid.org/0000-0002-2013-8096"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marla Weetall","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071707596","display_name":"Christopher R. Trotta","orcid":"https://orcid.org/0000-0001-5749-0133","observed_orcids":["https://orcid.org/0000-0001-5749-0133"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Trotta","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032141712","display_name":"Katherine Cintron","orcid":"https://orcid.org/0000-0003-4190-1609","observed_orcids":["https://orcid.org/0000-0003-4190-1609"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine Cintron","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027918265","display_name":"Jiyuan Ma","orcid":"https://orcid.org/0000-0001-6538-4023","observed_orcids":["https://orcid.org/0000-0001-6538-4023","https://orcid.org/0009-0000-8185-1410"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]},{"id":"https://openalex.org/I4405264409","display_name":"PMV Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/01vc3c277","country_code":"US","type":"company","lineage":["https://openalex.org/I4405264409"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jiyuan Ma","raw_affiliation_strings":["PMV Pharmaceuticals Inc., Cedar Brook Corporate Center, 8 Clarke Drive, Cranbury Township, New Jersey 08512","PTC Therapeutics South Plainfield, NJ 07080, USA","US Food and Drug Administration, 629 Cranbury Road, 2 nd Floor, East Brunswick, NJ 08816"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PMV Pharmaceuticals Inc., Cedar Brook Corporate Center, 8 Clarke Drive, Cranbury Township, New Jersey 08512","institution_ids":["https://openalex.org/I4405264409"]},{"raw_affiliation_string":"PTC Therapeutics South Plainfield, NJ 07080, USA","institution_ids":["https://openalex.org/I4210134724"]},{"raw_affiliation_string":"US Food and Drug Administration, 629 Cranbury Road, 2 nd Floor, East Brunswick, NJ 08816","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100360892","display_name":"Min Jung Kim","orcid":"https://orcid.org/0000-0003-4949-1237","observed_orcids":["https://orcid.org/0000-0003-4949-1237"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Min Jung Kim","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021647682","display_name":"Bansri Furia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bansri Furia","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019285587","display_name":"CHARLES M. ROMFO","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Romfo","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032509378","display_name":"Jason D. Graci","orcid":"https://orcid.org/0000-0002-6329-9164","observed_orcids":["https://orcid.org/0000-0002-6329-9164"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason D. Graci","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101700361","display_name":"Wencheng Li","orcid":"https://orcid.org/0000-0003-1783-2009","observed_orcids":["https://orcid.org/0000-0003-1783-2009"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wencheng Li","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005987573","display_name":"Joshua Du","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua Du","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063193141","display_name":"Josephine Sheedy","orcid":"https://orcid.org/0000-0001-9615-2727","observed_orcids":["https://orcid.org/0000-0001-9615-2727"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Josephine Sheedy","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087253726","display_name":"Jean Hedrick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jean Hedrick","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088274566","display_name":"Nicole Risher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole Risher","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070670286","display_name":"Shirley Yeh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shirley Yeh","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013562958","display_name":"Hongyan Qi","orcid":"https://orcid.org/0000-0002-4639-299X","observed_orcids":["https://orcid.org/0000-0002-4639-299X"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hongyan Qi","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089722456","display_name":"Tamil Arasu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tamil Arasu","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102002444","display_name":"Seongwoo Hwang","orcid":"https://orcid.org/0000-0001-9034-594X","observed_orcids":["https://orcid.org/0000-0001-9034-594X"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Seongwoo Hwang","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":null,"display_name":"William Lennox","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Lennox","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056763549","display_name":"Ronald Kong","orcid":"https://orcid.org/0000-0002-4692-7499","observed_orcids":["https://orcid.org/0000-0002-4692-7499"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald Kong","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063241262","display_name":"Janet M. Petruska","orcid":"https://orcid.org/0000-0002-9733-0086","observed_orcids":["https://orcid.org/0000-0002-9733-0086"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janet Petruska","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011563257","display_name":"Young\u2010Choon Moon","orcid":"https://orcid.org/0000-0002-6230-4961","observed_orcids":["https://orcid.org/0000-0002-6230-4961"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Young-Choon Moon","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076539329","display_name":"John Babiak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Babiak","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113718497","display_name":"Thomas W. D. Davis","orcid":"https://orcid.org/0009-0004-2234-6122","observed_orcids":["https://orcid.org/0009-0004-2234-6122"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas W. Davis","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052124121","display_name":"Allan Jacobson","orcid":"https://orcid.org/0000-0002-5661-3821","observed_orcids":["https://orcid.org/0000-0002-5661-3821"]},"institutions":[{"id":"https://openalex.org/I166722992","display_name":"University of Massachusetts Chan Medical School","ror":"https://ror.org/0464eyp60","country_code":"US","type":"education","lineage":["https://openalex.org/I166722992"]},{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allan Jacobson","raw_affiliation_strings":[". Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, 368 Plantation Street, Worcester MA 01655",". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":"https://orcid.org/0000-0002-5661-3821","affiliations":[{"raw_affiliation_string":". Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, 368 Plantation Street, Worcester MA 01655","institution_ids":["https://openalex.org/I166722992"]},{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087990265","display_name":"Neil G. Almstead","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neil G. Almstead","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108911809","display_name":"Art Branstrom","orcid":"https://orcid.org/0000-0002-5917-6372","observed_orcids":["https://orcid.org/0000-0002-5917-6372"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Art Branstrom","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087545685","display_name":"Joseph M. Colacino","orcid":"https://orcid.org/0000-0002-0939-2341","observed_orcids":["https://orcid.org/0000-0002-0939-2341"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph M. Colacino","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":"https://orcid.org/0000-0002-0939-2341","affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076684353","display_name":"Stuart W. Peltz","orcid":"https://orcid.org/0000-0002-9158-9142","observed_orcids":["https://orcid.org/0000-0002-9158-9142"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stuart W. Peltz","raw_affiliation_strings":[". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ 07080","institution_ids":["https://openalex.org/I4210134724"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5050034826"],"corresponding_institution_ids":["https://openalex.org/I4210134724"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dihydroorotate-dehydrogenase-inhibitors","display_name":"dihydroorotate dehydrogenase inhibitors","score":0.921999990940094},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.9419999718666077},{"id":"https://openalex.org/keywords/leukemia","display_name":"leukemia","score":0.7200000286102295},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7960000038146973},{"id":"https://openalex.org/keywords/pyrimidine-biosynthesis","display_name":"pyrimidine synthesis","score":0.800000011920929},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.7480000257492065},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8410000205039978},{"id":"https://openalex.org/keywords/protein-protein-interaction","display_name":"protein-protein interaction","score":0.5509999990463257},{"id":"https://openalex.org/keywords/preclinical-safety-evaluation","display_name":"preclinical safety","score":0.6209999918937683},{"id":"https://openalex.org/keywords/pyrimidine-salvage-pathway","display_name":"pyrimidine salvage pathway","score":0.8289999961853027},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.5799999833106995}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.40407794713974},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3947221636772156},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.338453471660614},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2916741371154785}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.22509942","doi":"https://doi.org/10.1158/1535-7163.22509942","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22509942","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.22509942.v1","doi":"https://doi.org/10.1158/1535-7163.22509942.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22509942.v1","pdf_url":"https://aacr.figshare.com/ndownloader/files/39971826","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22509942","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figures_S1-S7_Supplementary_Tables_S1-S7_and_Supplementary_Materials_and_Methods_from_Targeting_of_Hematologic_Malignancies_with_PTC299_A_Novel_Potent_Inhibitor_of_Dihydroorotate_Dehydrogenase_with_Favorable_Pharmaceutical_Pro/22509942","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22509942","doi":"https://doi.org/10.1158/1535-7163.22509942","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22509942","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362610285.pdf","grobid_xml":"https://content.openalex.org/works/W4362610285.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2897748008","https://openalex.org/W4362545074","https://openalex.org/W2946581746","https://openalex.org/W3097596646","https://openalex.org/W2986945176","https://openalex.org/W4282916676","https://openalex.org/W3124884480","https://openalex.org/W4210368349","https://openalex.org/W4302024743","https://openalex.org/W7144366372"],"abstract_inverted_index":{"Supplementary":[0,3,14,25,39,57,73,94,109,112,128,156,170,182,192,206],"Figures":[1],"S1-S7:":[2,111],"Figure":[4,15,26,40,58,74,95],"S1":[5,114],"shows":[6,17,28,42,60,76,97,115,131,159,173,185,195,209],"chemical":[7],"Synthesis":[8],"and":[9,19,33,53,70,102,123,221],"biological":[10],"characterization":[11,20],"of":[12,21,37,81,100,121,135,162,178,190,214],"PTC299.":[13,191],"S2":[16,130],"generation":[18],"PTC299-resistant":[22],"HT1080":[23],"cells.":[24],"3":[27],"that":[29,43,61,77,132,145],"PTC299":[30,44,62,78,103,141,167,174],"interacts":[31],"with":[32,140,150],"inhibits":[34,45,79],"the":[35,98,116,119,133,160,186,196,202,210],"activity":[36,65],"DHODH.":[38],"S4":[41,172],"de":[46,179],"novo":[47,180],"UMP":[48],"production":[49,80],"in":[50,68,71,84,104,107,137,147,166,201,212,224],"both":[51],"sensitive":[52],"insensitive":[54],"cell":[55],"lines.":[56],"S5":[59,184],"has":[63],"broad":[64],"against":[66],"leukemia":[67],"vitro":[69],"vivo.":[72],"S6":[75,194],"VEGF":[82],"protein":[83],"tumor":[85],"cells":[86,122,138,148],"more":[87],"potently":[88],"than":[89],"does":[90],"brequinar":[91],"or":[92],"teriflunomide.":[93],"S7":[96,208],"comparison":[99],"GSK983":[101],"pharmacokinetic":[105],"study":[106],"mice;":[108],"Tables":[110],"Table":[113,129,157,171,183,193,207],"information":[117,198],"on":[118],"source":[120],"when":[124],"they":[125],"were":[126],"obtained.":[127],"metabolism":[134],"15N-glutamine":[136],"treated":[139,149],"is":[142],"similar":[143],"to":[144,217],"measured":[146],"brequinar,":[151],"a":[152],"known":[153],"DHODH":[154],"inhibitor.":[155],"S3":[158],"summary":[161],"enriched":[163],"proteins":[164],"identified":[165],"pull-down":[168],"samples.":[169],"species":[175],"selectivity:":[176],"inhibition":[177],"UMP.":[181],"preclinical":[187],"safety":[188],"profile":[189],"demographic":[197],"for":[199],"patients":[200],"NF-2":[203],"clinical":[204],"trial.":[205],"differences":[211],"expression":[213],"genes":[215],"related":[216],"pyrimidine":[218],"nucleotide":[219],"synthesis":[220],"salvage":[222],"pathway":[223],"hematopoietic":[225],"cancers":[226],"versus":[227],"solid":[228],"tumors.":[229]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2023-04-06T00:00:00"}